SEREVENT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SEREVENT contains one active pharmaceutical ingredient (API):

1 Salmeterol UNII 6EW8Q962A5 - SALMETEROL XINAFOATE

Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist. These pharmacological properties of salmeterol offer more effective protection against histamine-induced bronchoconstriction and produce a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting β2 agonists. Read about Salmeterol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SEREVENT DISKUS Inhalation powder	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AC12	Salmeterol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8141L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510607104170318
Country: CA	Health Products and Food Branch	Identifier(s): 02231129
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00013468, 00013474, 00148903, 00148926, 04650769, 05541746, 05702600, 05702623, 06118702, 06118719, 06468945, 06468951, 07320297, 07533030, 07533076, 08652498, 09707385, 11018397, 11692863, 11697694, 11861900, 11861917, 12453037, 12453043, 13624860, 13624877, 13867060
Country: EE	Ravimiamet	Identifier(s): 1000405, 1007907
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59489, 59490
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 115931
Country: FR	Base de données publique des médicaments	Identifier(s): 67274478, 69163238
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 100731, 139979, 147061, 147064, 162418, 162420, 186117, 33810, 368954, 374156, 377029
Country: HK	Department of Health Drug Office	Identifier(s): 35936
Country: IE	Health Products Regulatory Authority	Identifier(s): 36907, 59943, 72839
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3541, 6049
Country: IT	Agenzia del Farmaco	Identifier(s): 027890146
Country: JP	医薬品医療機器総合機構	Identifier(s): 2259708G3025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1001757, 1001758
Country: MT	Medicines Authority	Identifier(s): MA192/01002
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 438M93
Country: NL	Z-Index G-Standaard	Identifier(s): 13604627, 14039303
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 32808, 45616
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11643, 5495
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100088919, 100164566
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522523245, 8699522553228
Country: US	FDA, National Drug Code	Identifier(s): 0173-0520, 0173-0521
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/10.2.1/0350, A40/10.2.1/0064